CLPT
HealthcareClearPoint Neuro, Inc.
$14.19
+$0.16 (+1.14%)
Jan 5, 2026
Price History (1Y)
Analysis
ClearPoint Neuro, Inc. is a healthcare company that operates in the medical devices industry. With a market capitalization of $422.13 million and annual revenues of $34.33 million, the company has a relatively small scale compared to larger players in its sector. ClearPoint employs 115 people, indicating a moderate-sized workforce. From a financial perspective, the company's profitability is a concern, with negative net income of -$23.14 million and EBITDA of -$21.96 million over the trailing twelve months. The operating margin is -59.5% and profit margin is -67.4%, highlighting significant losses. However, ClearPoint has a healthy cash balance of $38.22 million and relatively low debt-to-equity ratio of 225.18. In terms of valuation, the company's forward P/E ratio is -17.63, indicating that investors are currently bearish on its prospects. The price to book ratio is 25.43 and price to sales ratio is 12.30, suggesting that ClearPoint is valued at a premium compared to some peers in the medical devices industry. Revenue growth has been moderate, with a year-over-year increase of 9.1%, although earnings growth is not available due to negative net income over the trailing twelve months.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Visit website →Key Statistics
- Market Cap
- $422.13M
- P/E Ratio
- N/A
- 52-Week High
- $30.10
- 52-Week Low
- $9.76
- Avg Volume
- 811.10K
- Beta
- 0.92
Company Info
- Industry
- Medical Devices
- Exchange
- NCM
- Country
- United States
- Employees
- 115